• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    V2X Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    5/19/25 4:24:47 PM ET
    $VVX
    Diversified Commercial Services
    Consumer Discretionary
    Get the next $VVX alert in real time by email
    false 0001601548 0001601548 2025-05-15 2025-05-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of The Securities Exchange Act of 1934

     

    Date of report (Date of earliest event reported): May 15, 2025

     

     

    V2X, Inc.

    (Exact Name of Registrant as Specified in Its Charter)

     

     

    Indiana

    (State or Other Jurisdiction of Incorporation)

     

    001-36341 38-3924636
    (Commission (IRS Employer
    File Number) Identification No.)

     

    1875 Campus Commons Drive, Suite 305

    Reston, VA 20191

    (Address of Principal Executive Offices) (Zip Code)

     

    (571) 481-2000

    (Registrant's Telephone Number, Including Area Code)

     

    Securities Registered Under Section 12(b) of the Act:

     

    Title of each class Trading
    symbol(s)
    Name of each exchange on which registered
    Common Stock, Par Value $0.01 Per Share VVX New York Stock Exchange

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

     

    ¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 8.01 Other Events.

     

    On May 15, 2025, V2X, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”), by and among the Company, Vertex Aerospace Holdco LLC (the “Selling Shareholder”) and RBC Capital Markets, LLC, as underwriter (the “Underwriter”), relating to the public offering (the “Offering”) of 2,000,000 shares of common stock, par value $0.01 per share (“common stock”), by the Selling Shareholder and up to 300,000 additional shares of common stock by the Selling Stockholder at the Underwriter’s option at any time on or before the 30th day after the date of the Prospectus (as defined below).

     

    The Underwriting Agreement contains customary representations, warranties, covenants and indemnification obligations of the Company, the Selling Shareholder and the Underwriter, as well as termination and other customary provisions.

     

    The Offering was made pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333- 267223) that was declared effective under the Securities Act of 1933, as amended, by the Securities and Exchange Commission on September 12, 2022, and a related prospectus supplement dated May 15, 2025 (the “Prospectus”).

     

    The Offering closed on May 19, 2025. The Company did not sell any securities in the Offering and will not receive any proceeds from the sale of the shares offered by the Selling Shareholder.

     

    The foregoing description of the Underwriting Agreement is qualified in its entirety by reference to the full text of the Underwriting Agreement, which is filed as Exhibit 1.1 to this Current Report on Form 8-K and incorporated herein by reference.

     

    The Underwriting Agreement and the above descriptions have been included to provide investors and security holders with information regarding the terms of the Underwriting Agreement. They are not intended to provide any other factual information about the Company or its subsidiaries or affiliates or equity holders. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of that agreement and as of specific dates, were solely for the benefit of the parties to the Underwriting Agreement, and may be subject to limitations agreed upon by the parties, including being qualified by confidential disclosures made by each contracting party to the other as a way of allocating contractual risk between them that differ from those applicable to investors. Moreover, the subject matter of the representations and warranties is subject to more recent developments. Accordingly, investors should be aware that these representations, warranties and covenants or any description thereof alone may not describe the actual state of affairs of the Company or its subsidiaries, affiliates, businesses or equity holders as of the date they were made or at any other time.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit
    No.
      Description
         
    1.1   Underwriting Agreement, dated May 15, 2025, by and among V2X, Inc., Vertex Aerospace Holdco LLC and RBC Capital Markets, LLC, as underwriter
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      V2X, INC.
       
    Dated: May 19, 2025 By: /s/ Sarita B. Malakar
        Sarita B. Malakar
        Corporate Secretary

     

     

     

    Get the next $VVX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VVX

    DatePrice TargetRatingAnalyst
    4/16/2025$51.00Underweight
    Morgan Stanley
    1/21/2025$64.00Buy
    Citigroup
    1/2/2025$72.00 → $65.00Strong Buy → Outperform
    Raymond James
    12/19/2024$70.00 → $58.00Outperform → Sector Perform
    RBC Capital Mkts
    12/12/2024$54.00Sell
    Goldman
    11/25/2024$80.00Buy
    BTIG Research
    10/11/2024$75.00Outperform
    Robert W. Baird
    1/5/2024$59.00 → $52.00Buy → Hold
    Stifel
    More analyst ratings